MAY 27, 2026 AT 07:40 PM

FDA approves AbbVie's (ABBV) pivekimab sunirine-pvzy for blastic plasmacytoid dendritic cell neoplasm

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.

Open Dashboard

#ABBVIE INC#ABBV.US#FDA#EQUITIES#US SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ABBVIE INC#ABBV#US EQUITIES